Your position:www.healthoo.com >> EN >> EN >> Formulation >> Hansoh Pharmas Zolbetuximab Receives BLA Acceptance for Gastric Cancer Treatment in China >> article
 
Hansoh Pharmas Zolbetuximab Receives BLA Acceptance for Gastric Cancer Treatment in China
Editor:xuezhe     Clicks:0    Date:2023-9-1 15:10:15
Keyword: Hansoh Pharma
Healthoo Information:
Hansoh Pharmas Zolbetuximab Receives BLA Acceptance for Gastric Cancer Treatment in China
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • The overhaul of Northeast Pharmaceutical came to an end in the summer ...
  • Technical transformation project of Jilin Beisha Pharmaceutical Co., L...
  • The project of NCPC Characteristic Synthetic Drug Base started, the fi...
  • Cellulose Ether Market Analysis: Pharmaceutical Industrys Growth Trend
  • Nine key words & hot events in the pharmaceutical industry in 2023 H1
  • Changes of global supply chain pattern of pharmaceutical products befo...
  • $161 million! China Biopharmaceutical completes acquisition of F-star ...
  • Shandong Jingxin Pharmaceutical Co., Ltd. has entered the stage of equ...
  • Is the class solidified? From Biotech to Pharma
  • Nicolas Pharmaceutical, the life death bureau of innovative drug paten...
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463